Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Madrigal Pharmaceuticals Inc (NASDAQ:MDGL)

22.33
Delayed Data
As of Sep 20
 +0.40 / +1.82%
Today’s Change
10.00
Today|||52-Week Range
22.96
+49.87%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2016
Quarter 4
2016
Quarter 1
2017
Quarter 2
2017
Operating ActivitiesNet Income / Starting Line-8.7M-7.7M-6.0M-8.3M
 
 
 
 
 
Total Other Cash Flow8.4M576.2K602.0K676.0K
 
 
 
 
 
Funds From Operations-469.8K-7.2M-5.4M-7.7M
 
 
 
 
 
Funds From/For Other Operating Expenses-7.4M-1.9M-1.6M-13.0K
 
 
 
 
 
Net Cash Flow - Operating Activities7.0M-5.3M-3.8M-7.7M
 
 
 
 
 
 
InvestingIncrease In Investments38.4M-7.7M-22.1M-9.0M
 
 
 
 
 
Decrease In Investments-32.2M17.6M11.6M8.5M
 
 
 
 
 
Capital Expenditures-1.5K-1.6K-2.0K-123.0K
 
 
 
 
 
Fixed Asset Disposal216.4K215.1K----
 
 
 
Other Investing - Sources5.8M0.000.000.00
 
 
Net Cash Flow Investing12.2M10.1M-10.6M-647.0K
 
 
 
 
 
 
FinancingShort Term Borrowings--0.000.000.00--
Long Term Borrowings0.000.000.000.00--
Long Term Debt Reduction4.6M0.000.000.00
 
 
Net Proceeds Stock Sale0.006.0M3.4M34.9M
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends----------
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing0.000.000.000.00--
Other Uses - Financing0.000.000.000.00--
Net Cash Flow - Financing13.1M6.0M3.4M34.9M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash----------
 
Net Change In Cash32.3M10.8M-10.9M26.6M